PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Rare case of CAR-T resistance underscores manufacturing hurdles

The inadvertent genetic engineering of a single leukemic cell during clinical manufacturing of a CAR-T cancer therapy led to fatal treatment resistance in one pati...
Continue Reading →
news

Ciprofloxacin dramatically affects the mitochondrial genome

Researchers have shown how ciprofloxacin, a fluoroquinolone, affects mitochondrial DNA, and could be the cause of side effects experienced from use of the drug. De...
Continue Reading →
news

In Small Patient Group, Sarepta’s DMD Gene Therapy Gives Some Hope

Sarepta Therapeutics’ experimental gene-therapy treatment for Duchenne muscular dystrophy (DMD) is showing some early signs of promise. Patients who received the ther...
Continue Reading →
news

Immunotherapy: ‘Killer’ cells get boost in fight against cancer

  Recent research may have just revealed a way to make a highly successful form of immunotherapy available to thousands of people with cancer. An innovative a...
Continue Reading →
news

A compound found in apples can slow down aging

A natural compound called fistein, found in apples, can help slow down ageing New research has identified...
Continue Reading →
news

Drug resistance: ‘Trojan horse’ compound kills bacteria from within

By disrupting their nutrition, we could kill bacteria from within.   Gallium — an iron-like compoun...
Continue Reading →
news

Arcis Biotechnology raises £1.25 million (USD $1.63 million) funding and opens further £0.5 million investment opportunity through Capital Cell

£1.25 million already secured based on pre-money valuation of £18.2 million Additional funding will be used to further accelerate product development and company...
Continue Reading →
news

CPhI Annual Report 2018: Bio section bioLIVE report forecast bioconjugation expertise and increased productivity in bio over next 5-years

Smaller bioreactors and high-density perfusion techniques needed as manufacturing makes significant efficiency improvements.   Amsterdam, 27th September 2018: A...
Continue Reading →
news

Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-Thalassemia

Boston, USA and London, UK, October 04, 2018 / B3C newswire / -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives ...
Continue Reading →
news

Faulty immune system linked to UK’s leading cause of blindness

Research findings shared for National Eye Health Week (24 - 30 September) reveal a link between over-active immune systems, stimulated by poor diets and oxidative str...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC